Cancers Associated with Human Papillomavirus in American Indian and Alaska Native Populations - United States, 2013-2017
This report describes incidence of human papillomavirus--associated cancers in American Indian and Alaska Native populations in the United States during 2013-2017. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 17, 2020 Category: American Health Tags: American Indian - Alaska Native Health Cancer HPV Infection (Human Papillomavirus) MMWR Morbidity & Mortality Weekly Report Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Investor Update - September 16, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Rates Increasing Among 15-Year-Olds
MONDAY, Sept. 14, 2020 -- From 2011 to 2017, there was an increase in the proportion of U.S. 15-year-olds with at least one-dose or two-dose human papillomavirus (HPV) vaccination, according to a study published online Sept. 14 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Rises Among U.S. Kids, But Many Still Unprotected
MONDAY, Sept. 14, 2020 -- More U.S. kids are getting a recommended vaccine that protects against several cancers -- but there is still much room for improvement, a new study finds. At issue is the vaccine against human papillomavirus (HPV). Certain... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 14, 2020 Category: General Medicine Source Type: news

Genetic and Spatial Heterogeneity in Human Papillomavirus-Associated Oropharyngeal Cancer
Joseph Powell will discuss how heterogeneous subpopulations of HPV+ head and neck cancer cells drive unique disease states, cell-cell interactions, and microenvironment dynamics, and have... (Source: The Scientist)
Source: The Scientist - August 20, 2020 Category: Science Tags: Sponsored Webinars Source Type: news

HPV vaccination linked to lower risk of precancerous condition
(Wiley) Vaccination against the human papilloma virus (HPV) reduces the risk of a condition that often leads to cervical cancer, according to an analysis of Danish health registry data. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 5, 2020 Category: Cancer & Oncology Source Type: news

HPV Test Is Preferred Method for Cervical Cancer Screening: ACS HPV Test Is Preferred Method for Cervical Cancer Screening: ACS
New guidelines recommend human papillomavirus (HPV) testing as the preferred screening method, but cotesting and cytology alone are still acceptable options.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 4, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ACS Disagrees With CDC on HPV Vaccination in Adults ACS Disagrees With CDC on HPV Vaccination in Adults
The American Cancer Society's new guidance on human papillomavirus vaccination diverges from the Centers for Disease Control and Prevention's recommendations.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 3, 2020 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

American Cancer Society now recommends cervical cancer screening start at 25, not 21
Individuals with a cervix are now recommended to start cervical cancers screening at 25 and continue through age 65, with the primary human papillomavirus (HPV) testing every five years as the preferred method of testing, according to a new guideline released Thursday by the American Cancer Society. (Source: CNN.com - Health)
Source: CNN.com - Health - July 31, 2020 Category: Consumer Health News Source Type: news

American Cancer Society Recommends HPV Test
The new guideline calls for an initial cervix screening at age 25, followed by the human papillomavirus (HPV) test every five years, continuing through age 65, the guideline says. (Source: WebMD Health)
Source: WebMD Health - July 31, 2020 Category: Consumer Health News Source Type: news

Teen HPV Vaccination Rates Suboptimal
THURSDAY, July 30, 2020 -- Lack of parental intent to initiate and complete the human papillomavirus (HPV) vaccine series for adolescents is a major public health concern, according to a study published online July 21 in The Lancet Public... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 30, 2020 Category: Pharmaceuticals Source Type: news

HPV Shots: Safe and Effective, But Many Parents Still Hesitate
WEDNESDAY, July 29, 2020 -- More than a decade of research has shown that the human papillomavirus (HPV) vaccine protects against a host of cancers, yet a new study finds that only half of American teens complete the multiple-shot regimen. Why?... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 29, 2020 Category: General Medicine Source Type: news

BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
BD Onclarity™ HPV Assay is the only FDA-approved HPV assay to individually identify and report genotypes beyond 16, 18 and 45 FRANKLIN LAKES, N.J., July 22, 2020 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX... Diagnostics, Oncology, FDA BD , Onclarity, HPV Assay, human papillomavirus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 22, 2020 Category: Pharmaceuticals Source Type: news

Pap/HPV Cotesting Better for Cervical Cancer Screening in Over 30s
TUESDAY, July 14, 2020 -- Liquid-based cytology (LBC) and human papillomavirus (HPV) cotesting enhances screening for cervical cancer (CxCa) and precancer among women aged 30 years and older, according to a study published online July 8 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Scientists find firm link between prostate cancer and HPV for the first time 
Prostate cancer has been convincingly linked to the sexually transmitted human papillomavirus (HPV) for the first time. (Source: the Mail online | Health)
Source: the Mail online | Health - July 14, 2020 Category: Consumer Health News Source Type: news

American Cancer Society Updates HPV Vaccination Guidelines
WEDNESDAY, July 8, 2020 -- The American Cancer Society has updated guidelines on human papillomavirus (HPV) vaccination, emphasizing that vaccination should be routinely offered at age 9 to 12 years; the updated recommendations were published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 8, 2020 Category: Pharmaceuticals Source Type: news

Study: 'Anti-vaxxers' gain traction against HPV vaccine on Facebook
(University of Missouri-Columbia) One of the biggest social media sites -- Facebook -- has allowed " anti-vaxxers " to gain a stronger voice against the use of the human papillomavirus, or HPV, vaccine, according to a new study from a media expert at the University of Missouri. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 8, 2020 Category: Cancer & Oncology Source Type: news

Artificial Intelligence Provides Benefit for Cervical Cancer Screening
WEDNESDAY, July 1, 2020 -- For women undergoing human papillomavirus (HPV)-based cervical cancer screening, automated evaluation of p16/Ki-67 dual-stained (DS) slides reduces the number of colposcopies compared with current standards, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 1, 2020 Category: Pharmaceuticals Source Type: news

School HPV vaccine policies could result in higher vaccination rates, reduction in cancers
FINDINGSA UCLA-led study has found that in 2 of 3 states and jurisdictions with policies that require students entering school to receive the human papillomavirus vaccine, vaccination rates among 13-to-17-year-olds were significantly higher than in surrounding states without such policies.In Rhode Island, the vaccination rate among adolescents was 91%, compared with an average of 78% in neighboring non-policy states. In the District of Columbia, the rate was 89%, compared with 72% for nearby non-policy states. Virginia, which is in the same region as the district, was the one state with a vaccination policy that showed no ...
Source: UCLA Newsroom: Health Sciences - June 29, 2020 Category: Universities & Medical Training Source Type: news

AI dual-stain approach improved accuracy, efficiency of cervical cancer screening
(NIH/National Cancer Institute) In a new study, a computer algorithm improved the accuracy and efficiency of cervical cancer screening compared with cytology (Pap test), the current standard for follow-up of women who test positive with primary human papillomavirus (HPV) screening. The algorithm was developed and the study conducted by investigators at the National Cancer Institute (NCI), part of the National Institutes of Health, in collaboration with researchers from several other institutions. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2020 Category: Cancer & Oncology Source Type: news

Multilevel Interventions May Boost HPV Vaccination Rates
FRIDAY, June 19, 2020 -- Multilevel, provider-oriented interventions may improve human papillomavirus (HPV) vaccine series initiation and completion, according to a study published in the June 1 issue of Pediatrics. Rebecca B. Perkins, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 19, 2020 Category: Pharmaceuticals Source Type: news

Multilevel interventions improve HPV vaccination rates of series initiation and completion
(Boston Medical Center) New research from Boston Medical Center shows that providing education and training to pediatric and family medicine providers about the importance of human papillomavirus (HPV) vaccines, in tandem with healthcare systems changes including starting an HPV vaccination series before the age of 11, improves the overall rate of HPV vaccinations among adolescent patients. HPV vaccinations can help reduce rates of HPV-related cancers, as well as play a role in reducing race- and income-related disparities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2020 Category: Cancer & Oncology Source Type: news

HPV Vaccines That Work in U.S. Women May Miss the Target in Women From Other Countries
A research team at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center has found that the same vaccination programs that target human papillomavirus (hrHPV) strains in the United States may not be as effective in protecting other populations of women from the disease. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - June 4, 2020 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Press Release cancer Norris Cotton Cancer Center Source Type: news

Wording of vaccination messages influences behavior
(Washington State University) An experiment by Washington State University researchers revealed that relatively small differences in messages influenced people's attitudes about the human papillomavirus or HPV vaccine, which has been shown to help prevent cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2020 Category: International Medicine & Public Health Source Type: news

HPV vaccines that work in US women may miss the target in women from other countries
(Dartmouth-Hitchcock Medical Center) Most cervical cancers are caused by persistent infection with high-risk human papillomavirus (hrHPV). Different vaccines are available to protect against HPV. Researchers at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center have shown a very different prevalence of hrHPV in Honduras compared to the United States, and concluded that the same vaccination programs that target hrHPV strains in the U.S. may not be as effective in protecting women in other countries from the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2020 Category: Cancer & Oncology Source Type: news

World First: Saliva Test Detects Occult HPV Oral Cancer World First: Saliva Test Detects Occult HPV Oral Cancer
A saliva test still under development has scored a world first: it led to a finding of oral cancer after detecting rising human papillomavirus DNA levels in subsequent oral rinses.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 19, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

The interaction between pubertal timing and childhood maltreatment on the risk of human papillomavirus infection among adolescent girls and young women - Niu L, Hoyt LT, Salandy A, Nucci-Sack A, Shankar V, Strickler H, Burk RD, Schlecht NF, Diaz A.
PURPOSE: The goal of this study was to evaluate the effect of pubertal timing, and its interaction with prior childhood maltreatment, on the risk of cervical human papillomavirus (HPV) among sexually active adolescent minority female adolescents and young ... (Source: SafetyLit)
Source: SafetyLit - May 16, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Mouth cancer: A sexually transmitted disease could increase your risk - symptoms to spot
MOUTH cancer is the sixth most common cancer in the world. Around one in every 50 people are diagnosed with mouth cancer in the UK. Some types of cancer are linked to the human papillomavirus infection in the mouth. It's likely that some types of HPV are spread by oral sex. Can a sexual virus cause mouth cancer and if so what are the symptoms to spot? (Source: Daily Express - Health)
Source: Daily Express - Health - May 11, 2020 Category: Consumer Health News Source Type: news

Polio, Measles Outbreaks ‘Inevitable’, Say Vaccine Experts
A young boy in Pakistan receives an oral polio vaccine (OPV). Credit: Ashfaq Yusufzai/IPSBy Laura MackenzieMay 6 2020 (IPS) Interruptions to vaccination programmes caused by the COVID-19 pandemic could result in new waves of measles or polio outbreaks, health experts warn. A growing number of one-off immunisation campaigns and national routine vaccine introductions are being delayed amid social distancing and other measures to curb the spread of SARS-CoV-2, leaving millions unprotected. With both preventive campaigns and routine immunisations impacted, “we’ll have an increasing number of children who will becom...
Source: IPS Inter Press Service - Health - May 6, 2020 Category: International Medicine & Public Health Authors: Laura Mackenzie Tags: Global Headlines Health TerraViva United Nations Source Type: news

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer
             Basel, 21 April 2020 - Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval for the cobas ® HPV test for use on the fully automated, high-throughput cobas® 6800/8800 Systems. The cobas® HPV test identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples. Persistent high-risk HPV infections can develop into pre cancerous lesions and, if left untreated, these lesions can progress to cervical cancer.“The approval ...
Source: Roche Media News - April 21, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer
Basel, 21 April 2020 - Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval for the cobas ® HPV test for use on the fully automated, high-throughput cobas® 6800/8800 Systems. The cobas® HPV test identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples. Persistent high-risk HPV infections can develop into p recancerous lesions and, if left untreated, these lesions can progress to cervical cancer. (Source: Roche Investor Update)
Source: Roche Investor Update - April 21, 2020 Category: Pharmaceuticals Source Type: news

Human papillomavirus confers radiosensitivity in oropharyngeal cancer cells
(Impact Journals LLC) The cover for issue 16 of Oncotarget features Figure 6, 'Radiation-induced DNA damage measured byγ-H2AX foci formation at a specified time point after 10 Gy irradiation,' by Zhang, et al. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 21, 2020 Category: International Medicine & Public Health Source Type: news

Human Papillomavirus Vaccination Estimates Among Adolescents in the Mississippi Delta Region: National Immunization Survey ‑Teen, 2015-2017
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - April 16, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Trends in Incidence of Cancers of the Oral Cavity and Pharynx --- United States 2007--2016
From 2007 to 2016, incidence of cancers of the oral cavity and pharynx combined increased. The increase could be driven by increases in human papillomavirus-associated cancers. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 16, 2020 Category: American Health Tags: Cancer HPV-Associated Cancers MMWR Morbidity & Mortality Weekly Report Oral Cancer Source Type: news

HPV Viral Load and Long-Term Survival in Cervical Cancer HPV Viral Load and Long-Term Survival in Cervical Cancer
This study investigated the association of high-risk human papillomavirus viral load and prognosis of patients with cervical cancer. How does a high viral load impact therapeutic response?American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 14, 2020 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Therapeutic HPV vaccine may improve outcomes in advanced cervical cancer
(American Association for the Advancement of Science) Combining a therapeutic vaccine for human papilloma virus (HPV) with two standard chemotherapy drugs may extend survival in patients with advanced, recurrent cervical cancer, according to a phase 1/2 trial involving 77 patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 18, 2020 Category: Cancer & Oncology Source Type: news

Race, Insurance Status Linked to Lower Cancer Survival
MONDAY, March 16, 2020 -- Nonwhite, uninsured patients with clinically favorable human papillomavirus (HPV)-associated squamous cell carcinoma of the head and neck (SCCHN) have higher mortality than their white peers, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2020 Category: Pharmaceuticals Source Type: news

Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - March 12, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

HPV infections can be eliminated if both boys and girls are vaccinated
(Karolinska Institutet) The human papillomavirus (HPV) causes, amongst other diseases, cancer of the cervix and oropharynx. A Swedish-Finnish study published in The Journal of Infectious Diseases now shows that the most oncogenic HPV types can be eliminated, but only if both girls and boys are vaccinated. Both genders will be offered vaccination in Sweden as of 2020. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 12, 2020 Category: Cancer & Oncology Source Type: news

Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention
Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of CINtec®PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus (HPV) using the cobas ® 4800 HPV Test. This biomarker technology simplifies clinical decision making by providing easy to understand results so that clinicians and women are clear on next steps. The CINtecPLUS Cytology test identifies those women whose HPV infections are most likely to be associated with cervical pre-cancers. It...
Source: Roche Media News - March 11, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention
Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of CINtec®PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus (HPV) using the cobas ® 4800 HPV Test. This biomarker technology simplifies clinical decision making by providing easy to understand results so that clinicians and women are clear on next steps. (Source: Roche Investor Update)
Source: Roche Investor Update - March 11, 2020 Category: Pharmaceuticals Source Type: news

HPV Tied to Miscarriages and Preterm Births HPV Tied to Miscarriages and Preterm Births
Pregnant women infected with human papillomavirus (HPV) may be at increased risk for miscarriages and preterm deliveries, a review of past research suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 3, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

HPV Biomarkers Linked to Improved Survival With Esophageal Dysplasia, Adenocarcinoma HPV Biomarkers Linked to Improved Survival With Esophageal Dysplasia, Adenocarcinoma
Human papillomavirus (HPV) positivity and HPV biomarkers are associated with improved survival in adults with Barrett high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC), according to a new study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 21, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Gay Men Underestimate Their Risks From HPV
THURSDAY, Feb. 20, 2020 -- Young men who have sex with other men don't fully grasp their risk for human papillomavirus (HPV) infection, due to a lack of information from health care providers, researchers say. Interviews with men in their early 20s... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 20, 2020 Category: General Medicine Source Type: news

Young men unaware of risks of HPV infection and need for HPV vaccination
(Rutgers University) Young sexual minority men -- including those who are gay, bisexual, queer or straight-identified men who have sex with men -- do not fully understand their risk for human papillomavirus (HPV) due to a lack of information from health care providers, according to Rutgers researchers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 11, 2020 Category: International Medicine & Public Health Source Type: news

One HPV Vaccine Dose May Be As Effective As Multiple, Study Finds
BOSTON (CBS) — It is currently recommended that boys and girls under age 15 get two doses of the human papillomavirus (HPV) vaccine but a new study published in the journal Cancer finds that just one dose may be as effective. HPV is the most common sexually transmitted infection and certain strains of the virus are associated with cervical cancer in women. Researchers at the University of Texas looked at more than 130,000 females and found that one dose of the HPV vaccine was as effective as multiple doses for preventing cervical changes that often lead to cervical cancer. The hope is that if only one dose is require...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 10, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall HPV vaccine Source Type: news

Single Dose of HPV Vaccine May Cut Preinvasive Cervical Disease
MONDAY, Feb. 10, 2020 -- Receipt of one, two, or three doses of the human papillomavirus (HPV) vaccine among females aged 15 to 19 years is associated with reduced incidence of preinvasive cervical disease at five years compared to that seen in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 10, 2020 Category: Pharmaceuticals Source Type: news

One Dose of HPV Vaccine May Protect Against Cervical Cancer
MONDAY, Feb. 10, 2020 -- A single dose of the human papillomavirus (HPV) vaccine works as well as multiple doses to protect older teen girls against preinvasive cervical disease, which can develop into cervical cancer, researchers say. For the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 10, 2020 Category: General Medicine Source Type: news

Single HPV vaccine dose may be effective against cervical cancer
(Wiley) New research published in CANCER indicates that a single dose of the human papillomavirus (HPV) vaccine is as effective as multiple doses for preventing preinvasive cervical disease, which can later develop into cervical cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2020 Category: Cancer & Oncology Source Type: news